Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole vs placebo for prevention of NSAID-associated gastric/duodenal ulcers
jRCT2080220521Phase 3
- Sponsor
- AstraZeneca
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Peptic ulcer disease (PUD), gastric ulcer and duodenal ulcer comparing Esomeprazole 20 mg once daily with Placebo (2 arms).
02
Drugs
esomeprazole
03
Conditions
Peptic ulcer disease (PUD)gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on jRCT2080220521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220521.